peripartum cardiomyopathy


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

per·i·par·tum car·di·o·my·op·a·thy

cardiac failure due to heart muscle disease in the period before, during, or after delivery.

peripartum cardiomyopathy

Cardiology A rare but often fatal–50-85% mortality–form of dilated cardiomyopathy, defined as heart failure–HF occurring in the last month of pregnancy or within 5 months of delivery in absence of an identifiable cause of HF, and without demonstrable preexisting or concurrent heart disease; findings include cardiothoracic ratio > 0.55, a left ventricular ejection fraction < 50%, and a diastolic dimension > 95th percentile for age and body-surface area or recent pregnancy where heart muscle is weakened and cannot pump blood efficiently; ↓ heart function affects lungs, liver, and other systems Risk factors Obesity, personal or family Hx of heart disease–eg, myocarditis, use of certain drugs, smoking, alcoholism, multiple pregnancies, race, malnourishment, muscle degeneration, fibrosis

peripartum cardiomyopathy

Dilated cardiomyopathy occurring either in the last month of pregnancy or in the six months after delivery. Its cause is unknown, but it occurs more often in older and multiparous women.
See also: cardiomyopathy
References in periodicals archive ?
Peripartum cardiomyopathy characteristics and outcome in tertiary care hospital.
Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study.
Overall, treatment of peripartum cardiomyopathy follows a similar plan to conventional heart failure treatment.
Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy.
Levosimendan reduces pulmonary capillary wedge pressure and improves cardiac output of patients with peripartum cardiomyopathy.
The diagnosis of peripartum cardiomyopathy was made and the patient was treated for congestive heart failure with diuretics, digitalis and angiotensin converting enzyme inhibitors (ACE-I).
High prevalence of viral genomes and inflammation in peripartum cardiomyopathy.
The one death among 1,052 patients treated with Injectafer in the postpartum/heavy uterine bleeding trials was in a woman found to have peripartum cardiomyopathy on autopsy.
NEW ORLEANS -- Full recovery of left ventricular function is significantly less likely in black patients than in white patients with peripartum cardiomyopathy, Dr.
Peripartum cardiomyopathy (PPCM) is a rare cardiac complication and diagnosis includes clinical (development of cardiac failure in the last month of pregnancy or within 5 months after delivery, absence of an identifiable cause of cardiac failure and absence of recognizable heart disease prior to the last month of pregnancy) and echographic (left ventricular systolic dysfunction) criteria (28-29).
On the other hand, there are unique diseases such as Peripartum Cardiomyopathy (PPCM), which most commonly present in the post-partum period to women with no other structural heart disease.